Development of nanostars as a biocompatible tumor contrast agent: toward in vivo SERS imaging
Antoine D’Hollander,1–3 Evelien Mathieu,1,4 Hilde Jans,1 Greetje Vande Velde,2,3 Tim Stakenborg,1 Pol Van Dorpe,1,4 Uwe Himmelreich,2,3 Liesbet Lagae1,4 1Department of Life Science Technology, Imec, 2Department of Imaging and Pathology, Faculty of Medicine, Biomedical MRI Unit,...
Saved in:
Main Authors: | D’Hollander A, Mathieu E, Jans H, Vande Velde G, Stakenborg T, Van Dorpe P, Himmelreich U, Lagae L |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/4bb786e4d813423d9c2bcb7e7f32daeb |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gold Nanostars: A Novel Platform for Developing 211At-Labeled Agents for Targeted Alpha-Particle Therapy
by: Liu Y, et al.
Published: (2021) -
Photothermal ablation of inflammatory breast cancer tumor emboli using plasmonic gold nanostars
by: Crawford BM, et al.
Published: (2017) -
Cationic Peptide-Modified Gold Nanostars as Efficient Delivery Platform for RNA Interference Antitumor Therapy
by: Si Chen, et al.
Published: (2021) -
Shape-dependent antibacterial effects of non-cytotoxic gold nanoparticles
by: Penders J, et al.
Published: (2017) -
Stable in Biocompatible Buffers Silver Nanoisland Films for SERS
by: Alexey Skvortsov, et al.
Published: (2021)